Market Wrap

Indian equity markets ended lower on Friday after opening with a sharp gap-down, although strong buying interest in the latter half of the session helped the Nifty recover from intraday lows and close above the crucial 24,000 mark.

The benchmark index declined around 0.64%, reflecting continued caution among investors amid mixed global cues and uncertainty around foreign fund flows.

Sectorally, Pharma emerged as the standout performer, with the Nifty Pharma Index confirming a breakout from a symmetrical triangle pattern, signaling a potential continuation of its broader uptrend.

Global markets remained largely range-bound as investors awaited fresh economic data, central bank commentary, and clarity on geopolitical developments. Market participants also remained focused on earnings expectations, global bond yield movements, and international trade-related developments.

What's Ahead

Markets are likely to remain stock-specific in the near term, with corporate earnings expected to drive sectoral and individual stock movements. Investors will closely monitor upcoming U.S. economic data, commentary from the Federal Reserve, and any progress in global trade negotiations for cues on market direction and foreign investment flows.

From a technical perspective, Nifty's ability to sustain above key support levels will be crucial, while defensive sectors such as Pharma could continue to attract investor interest if broader market uncertainty persists.

Market Snapshots

Institutional Activity

Sectoral Performance